BGMS vs SMG

For growth investors, The Scotts Miracle-Gro Company (SMG) is the stronger pick with -3.

9% revenue growth year-over-year, versus -89. 8% for Bio Green Med Solution, Inc. (BGMS). The Scotts Miracle-Gro Company (SMG) offers the better valuation at 25. 4x trailing P/E (14. 3x forward), making it the more compelling value choice. Analysts rate The Scotts Miracle-Gro Company (SMG) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, The Scotts Miracle-Gro Company (SMG) delivered a total return of -68.

4%, compared to -83. 4% for Bio Green Med Solution, Inc. (BGMS). Over 10 years, the gap is even starker: SMG returned +34. 9% versus BGMS's -83. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), The Scotts Miracle-Gro Company (SMG) is the lower-risk stock at 1.

10β versus Bio Green Med Solution, Inc. 's 2. 04β — meaning BGMS is approximately 86% more volatile than SMG relative to the S&P 500.

By revenue growth (latest reported year), The Scotts Miracle-Gro Company (SMG) is pulling ahead at -3.

9% versus -89. 8% for Bio Green Med Solution, Inc. (BGMS). On earnings-per-share growth, the picture is similar: The Scotts Miracle-Gro Company grew EPS 504. 9% year-over-year, compared to 92. 2% for Bio Green Med Solution, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

The Scotts Miracle-Gro Company (SMG) is the more profitable company, earning 4.

3% net margin versus -260. 7% for Bio Green Med Solution, Inc. — meaning it keeps 4. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SMG leads at 10. 5% versus -279. 2% for BGMS. At the gross margin level — before operating expenses — BGMS leads at 100. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, SMG (4.

2% yield) pays a dividend. BGMS does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, The Scotts Miracle-Gro Company (SMG) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.

10), 4. 2% yield). Bio Green Med Solution, Inc. (BGMS) carries a higher beta of 2. 04 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (SMG: +34. 9%, BGMS: -83. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (BGMS (Healthcare) and SMG (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: BGMS is a small-cap quality compounder stock; SMG is a small-cap income-oriented stock. SMG pays a dividend while BGMS does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.